BRIEF-Hyperfine Secures FDA Approval for Optive AI on Swoop® System
Reuters
Dec 15, 2025
BRIEF-Hyperfine Secures FDA Approval for Optive AI on Swoop® System
Dec 15 (Reuters) - Hyperfine Inc HYPR.O:
HYPERFINE ANNOUNCES FDA CLEARANCE OF THE FIRST OPTIVE AI™ SOFTWARE UPDATE WITH ADVANCED DIFFUSION IMAGING CAPABILITY, FOCUSED ON ENHANCING STROKE DETECTION WITH THE SWOOP® SYSTEM
Source text: ID:nBw9kvncDa
Further company coverage: HYPR.O
((Reuters.Briefs@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.